scholarly journals Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib

2021 ◽  
Vol Volume 14 ◽  
pp. 5507-5519
Author(s):  
Candida Vitale ◽  
Jamie Lynn Gibbons ◽  
Alessandra Ferrajoli
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Clinical Utility ◽  
Lymphocytic Leukemia ◽  
Targeted Treatment

A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia

2020 ◽  
Vol 85 ◽  
pp. 20-26
Author(s):  
Paraskevi Karousi ◽  
Panagiotis G. Adamopoulos ◽  
Sotirios G. Papageorgiou ◽  
Vasiliki Pappa ◽  
Andreas Scorilas ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Clinical Utility ◽  
Prognostic Biomarker ◽  
Lymphocytic Leukemia

scholarly journals Clinical Utility of the Collect Scale To Assess Comorbidities In Patients With Chronic Lymphocytic Leukemia

2014 ◽  
Vol 17 (7) ◽  
pp. A522
Author(s):  
La Serna J. De ◽  
F. Carbonell ◽  
P. Giraldo ◽  
A. Lopez ◽  
I. González ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Clinical Utility ◽  
Lymphocytic Leukemia

scholarly journals Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

2015 ◽  
pp. 75
Author(s):  
Marco Montillo ◽  
Anna Maria Frustaci ◽  
Alessandra Tedeschi ◽  
Paola Picardi ◽  
Roberto Cairoli
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Clinical Utility ◽  
Lymphocytic Leukemia

scholarly journals CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia

2018 ◽  
Vol 14 (6) ◽  
pp. 499-513 ◽  
Author(s):  
Paula Cramer ◽  
Julia von Tresckow ◽  
Jasmin Bahlo ◽  
Anja Engelke ◽  
Petra Langerbeins ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Minimal Residual Disease ◽  
Phase Ii ◽  
Residual Disease ◽  
Lymphocytic Leukemia ◽  
Targeted Treatment ◽  
Phase Ii Trials ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document